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ABSTRACT
Patent medicine vendors (PMVs) are a ubiquitous feature of the informal health sector in Nigeria. A previ-
ous study on healthcare-seeking behaviour of persons with chronic cough in southern Nigeria found that 
over 60% of respondents chose the PMV as a healthcare provider of first instance. This study sought to 
determine the willingness and capability of PMVs to play a role in the national tuberculosis (TB)-control 
effort. Study sites were selected through a multi-stage sampling process. In total, 388 PMVs, 17 princi-
pal officers of PMV associations, and 17 community leaders were purposively selected. Sets of structured 
questionnaire were administered to the PMVs while information from the principal officers of PMV as-
sociations and community leaders was elicited through in-depth interviews and focus-group discussions 
(FGDs). Quantitative data were collated using the Epi Info software (version 6.04) and analyzed using the 
SPSS software (version 15). Most (90%) PMVs indicated that they would be ready to cooperate with the 
national TB-control programme, if trained. Seventy-three percent attended persons with prolonged cough 
in the course of their career. However, 48% did not know the cause of TB. Only 3% ever-attended a train-
ing session on TB control. Sixty-six percent completed at least 12 years of schooling with secondary school 
certificate. Eighty percent of the community leaders were happy with the work of PMVs. About two-thirds 
(65.6%) of the PMVs were male. The PMVs are positively disposed to playing roles in TB control. Given this 
positive disposition and their widespread acceptance in healthcare-delivery in the communities, they have 
potentials for playing a role in TB control in southern Nigeria. 
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INTRODUCTION
There is a growing body of evidence demonstrating 
the increasing incidence of tuberculosis (TB) in Ni-
geria with well-developed directly-observed treat-
ment short-course (DOTS) (1-3). Infected persons 
take a number of options, mainly private-sector 
operators, before identifying an appropriate DOTS 
clinic for treatment (4-5). 
Persons with undiagnosed TB are reservoirs for 
high levels of its transmission. Jochem and Walley 
noted that the contagion parameter suggests that 
where TB is endemic, each infectious case will re-
sult in 20-28 secondary infections (6). Delay in the 
diagnosis and treatment contributes to worsening 
complications due to TB. 
A recent study on healthcare-seeking behaviours of 
persons with TB in southern Nigeria revealed that 
chemists/patent medicine vendors (PMVs) and tra-
ditional healers respectively constituted the first 
port of call for 107 (48.4%) and 27 (12.2%) of the 
persons with TB in the states studied (2). The num-
ber relying on the traditional healers increases as 
they evaluate the effectiveness of the first options 
and seek alternative options. They begin to report 
to the DOTS clinics as the fourth or the last option. 
This practice is typical of the response pattern to 
health conditions in most Nigerian societies. For 
instance, several studies demonstrated that PMVs 
were the most common source of treatment for 
malaria in rural and urban communities in Nigeria 
(7-11). 
Despite their prominence in healthcare provision, 
relatively little is known about PMVs and how they 
work. Although PMVs are known to belong to PMV Onyeneho NG and Chukwu JN Patent medicine vendors and tuberculosis control
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associations, there are virtually no published stud-
ies on how PMV associations operate. The Pharma-
cy Law of Nigeria specifies that PMVs should sell 
only prepackaged patent medicines, which requires 
that the license be of at least 21 years and submits 
the names of two referees (12). Within their shops, 
PMVs have been observed to behave primarily as 
commercial salesmen, since around 75% simply 
sell what a customer requests for, and on other rare 
occasions, fills a prescription (9). In the remainder 
of the time, the PMV responds to customer requests 
for advice or a description of symptoms.
Given the massive and complex challenges of case-
finding, prompt diagnosis, and providing appro-
priate and quality treatment for persons with TB 
in the Nigerian context, it is important to better 
understand how the informal sector (PMVs) in-
volved in the treatment of TB actually works and 
identify the pathways of involving them in ensur-
ing prompt diagnosis and appropriate treatment 
of TB cases. 
MATERIALS AND METHODS
Study setting
The area is made up of people with very diverse 
cultural systems, beliefs, and healthcare-seek-
ing practices that are associated with the people’s 
myths about existence and differences in the levels 
of western education, urbanization, and access to 
modern health facilities and cultures.
With the promotion of the primary healthcare 
(PHC) system in Nigeria, communities in each state 
are linked to a PHC unit that provides services, in-
cluding disease control and eradication. In these 
units, there are DOTS services for persons with TB. 
Along with these formal healthcare-provisioning 
facilities are a plethora of PMVs and traditional 
healing homes. The PMVs constitute the primary 
focus of this study.
Study area and population
The study focused on the 14 states in the Ger-
man Leprosy and TB Relief Association-assisted 
DOTS programme in southern Nigeria. The states 
are Ekiti, Ondo, and Ogun states in Southwestern 
zone; Akwa Ibom, Bayelsa, Cross River, Delta, Edo, 
and Rivers states in South-south zone; and Abia, 
Anambra, Ebonyi, Enugu, and Imo in Southeast. 
The 2006 census put that the combined popula-
tion of these states is over 64,978,686 million. The 
cross-sectional approach was adopted in collecting 
quantitative and qualitative data from community 
members and PMVs in six states in the three geopo-
litical zones of southern Nigeria. 
Sampling and instruments 
The study used multiple instruments and followed 
a multi-stage random-sampling scheme. One state 
each was selected to represent each of the major 
geographic-political zones: Ogun state (Southwest), 
Akwa Ibom state (South-south), and Enugu state 
(Southeast). Local Government Areas (LGAs) were 
stratified into urban and rural LGAs, with one LGA 
randomly sampled from each stratum, yielding 
one urban and one rural LGA in each state (6 LGAs 
in total). In each urban LGA, the LGA headquar-
ter was purposively selected to give typical urban 
setting for the study, and in each rural LGA, two 
typical rural communities were randomly selected 
from a list of all communities in the LGA. 
Each study instrument was used as follows: 
a. In each selected site, the list of all the PMVs in 
each sampled community was collected from 
the PMV association. All the PMVs were enlist-
ed in the study and interviewed. In total, 388 
PMVs were enlisted and interviewed.
b. In each of the LGAs, a PMV association was 
identified, and 4-7 principal officers were iden-
tified (chairman, secretary, treasurer and/or 
public relations officer) and interviewed on 
their activities, particularly on their role in the 
management of TB. In total, 17 PMV leaders 
were interviewed in-depth in the three states 
covered.
c.  In each of the randomly-selected communities, 
the community leaders were identified and in-
terviewed. In total, 17 community leaders were 
interviewed in-depth from the selected LGAs.
Methods of data analysis
Simple descriptive statistics, such as mean, mode, 
median, and percentage and also graphic illustra-
tions were employed in characterizing data. Corre-
lation analysis was also conducted using non-para-
metric statistics, such as chi-square (χ2), to illustrate 
the relationship between certain sociodemographic 
variables and some key issues in the study, such as 
knowledge of TB and referral practices. 
Analysis of qualitative data placed emphasis on the 
interpretation, description, and recording/writing 
of what is said. To do this, relevant themes were 
developed for the coding and sorting of qualita-
tive data, and the Atlas.ti software (version 5.0) was 
used for managing qualitative data.Onyeneho NG and Chukwu JN Patent medicine vendors and tuberculosis control
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RESULTS
Sociodemographic characteristics of 
respondents
More than two-thirds (70.4%) of the PMVs were 
from the urban areas. Their ages ranged from less 
than 19 to 45 years and above. About half (49.7%) 
of the respondents were married (Table 1). Chris-
tians (97.4%) dominated the sample of PMVs. 
About a quarter (25.3%) of the PMVs spent less 
than five years in the profession. Those who spent 
5-9 years constituted 35.3% of the PMVs.  
Knowledge and practice about tuberculosis
More than two-thirds (72.9%) of the PMVs saw peo-
ple suffering from TB (Table 2). This was confirmed 
Table 1. Distribution of PMVs (n=388) by their sociodemographic characteristics 
Sociodemographic characteristics
 Rural
(n=115)
 Urban
(n=273)
 Total
(n=388)
Sex
   Male
   Female
84 (73.0)
31 (27.0)
179 (65.6)
94 (34.4)
263 (67.8)
125 (32.2)
Age* (years)
   ≤19 
   20-24 
   25-29 
   30-34 
   35-39 
   40-44 
   45+ 
-
13 (11.3)
26 (22.6)
29 (25.2)
14 (12.2)
12 (10.4)
21 (18.3)
5 (1.8)
32 (11.7)
83 (30.4)
65 (23.8)
32 (11.7)
26 (9.5)
30 (11.0)
5 (1.3)
45 (11.6)
109 (28.1)
94 (24.2)
46 (11.9)
38 (9.8)
51 (13.1)
Marital status
   Never-married
   Married
   Married before
52 (45.2)
60 (52.2)
3 (2.6)
35.7
57.9
1.8
191 (49.2)
193 (49.7)
4 (1.0)
Religious affiliation
   Catholic
   Protestant
   Pentecostal
   Muslim
   Other
61 (53.0)
25 (21.7)
29 (25.2)
-
-
120 (44.0)
72 (26.4)
71 (26.0)
6 (2.2)
4 (1.5)
181 (46.6)
97 (25.0)
100 (25.8)
6 (1.5)
4 (1.0)
Level of education attained
   No formal education
   FLSC
   WASC/GCE
   OND/NCE
   HND/first degree
   Above first degree
0.(0.0)
11 (9.6)
82 (71.3)
19 (16.5)
3 (2.6)
0 (0.0)
9 (3.3)
24 (8.8)
175 (64.1)
40 (14.7)
21 (7.7)
4 (1.5)
9 (2.3)
35 (9.0)
257 (66.2)
59 (15.2)
24 (6.2)
4 (1.0)
Length (years) in profession
   >5 
   5-9 
   10-14 
   15-19 
   20-24 
   25-29 
   30+ 
28 (24.3)
40 (34.8)
23 (20.0)
7 (6.1)
14 (12.2)
1 (0.9)
2 (1.7)
70 (25.6)
97 (35.5)
66 (24.2)
15 (5.5)
18 (6.6)
3 (1.1)
4 (1.5
98 (25.3)
137 (35.3)
89 (22.9)
22 (5.7)
32 (8.2)
4 (1.0)
6 (1.5)
Figures in parentheses indicate percentages *Mean age=33.21 years; mode=28 years; median=32 years; 
standard deviation±8.832 years; FLSC=First school-leaving certificate; HND=Higher national diploma; 
NCE=National certificate of education; WASC=West African school certificate; GCE=General certificate 
of education; OND=Ordinary national diplomaOnyeneho NG and Chukwu JN Patent medicine vendors and tuberculosis control
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in the qualitative data. A female community leader 
in Uyo confirmed that TB was common among the 
people in the communities. She said: 
… I have discovered that there is TB in this com-
munity, which disturbs and hinders many peo-
ple….
Earlier, while enumerating the health problems 
that confront people in the communities, without 
prompting, she said: 
... I have seen many cases of asthma and also the 
disease called TB has killed up to five people as 
I have discovered in this community…. In one 
household, it killed up to three people.
However, knowledge of TB was not so impres-
sive among the PMVs. Almost half (48.2%) of the 
PMVs did not know the causes of TB. Ironically, 
this segment of the respondents was more in the 
urban area (58.2%) than in the rural area (24.3%). 
However, more rural PMVs (95.7%) than the urban 
PMVs (3.7%) subscribed to the existence of super-
natural causes of TB. More urban PMVs than their 
rural counterparts thought that it was a disease of 
poverty and environment.
Very small proportions (5.2% and 8.5%) of the 
PMVs sent clients with prolonged cough and sus-
pected TB respectively to any laboratory for diag-
nosis before treatment (Table 3). Similarly, 57.2% 
would refer suspected TB cases to higher facilities. 
Most (82.0%) PMVs reported that they treated cases 
Table 2. Distribution of respondents (n=388) by knowledge of tuberculosis
Knowledge of tuberculosis Rural Urban Total
Seen a client with tuberculosis
   Yes
   No
87 (75.7)
28 (24.3)
196 (71.8)
77 (28.2)
283 (72.9)
105 (27.1)
Signs and symptoms of tuberculosis
   Cough
   Cough with blood
   Prolonged coughing (>2 weeks)
   Weight loss
   Hard cough
   Dry cough
   Difficult breathing
   Change in eye-colour
   Weak
   Change in skin-colour
44 (38.3)
33 (28.7)
32 (27.8)
17 (14.8)
15 (13.0)
19 (16.5)
26 (22.6)
44 (38.3)
33 (28.7)
32 (27.8)
147 (53.8)
73 (27.8)
92 (33.7)
73 (26.7)
13 (4.8)
25 (9.2)
44 (16.1)
147 (53.8)
76 (27.8)
92 (33.7)
197 (50.8)
109 (28.1)
124 (32.0)
90 (23.2)
28 (7.2)
44 (11.3)
70 (18.0)
191 (49.2)
109 (28.1)
124 (32.0)
Causes of tuberculosis
   Bacterial infection
   Witchcraft
   Smoking
   Dust
   Sharing utensils with infected person
   Ignorance
   Heredity
   Poor environment
   Poverty
   Do not know
37 (32.2)
5 (95.7)
44 (38.3)
29 (25.2)
22 (19.1)
15 (13.0)
18 (15.7)
10 (8.7)
8 (7.0)
28 (24.3)
47 (17.2)
10 (3.7)
45 (16.5)
56 (20.5)
35 (12.8)
20 (7.3)
29 (10.6)
28 (10.3)
31 (11.4)
159 (58.2)
84 (21.6)
15 (3.9)
89 (22.9)
85 (21.9)
57 (14.7)
35 (9.0)
47 (12.1)
38 (9.8)
39 (10.1)
187 (48.2)
Age (years) most at risk
   Children (>5)
   Children (5-10)
   Children (11-17)
   Adults (18-64)
   Aged (65+)
   All ages equally at risk
   Do not know
2 (1.7)
5 (4.3)
10 (8.7)
20 (17.4)
16 (13.9)
33 (28.7)
29 (25.2)
15 (5.5)
13 (4.8)
8 (2.9)
19 (7.0)
35 (12.8)
54 (19.8)
129 (47.3)
17 (4.4)
18 (4.6)
18 (4.6)
39 (10.1)
51 (13.1)
87 (22.4)
159 (40.7)
Figures in parentheses indicate percentagesOnyeneho NG and Chukwu JN Patent medicine vendors and tuberculosis control
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with prolonged cough (Table 4). Table 5 shows that 
28.9% of the PMVs treated suspected TB cases in 
their facilities. This is more in the urban communi-
ties (χ2=13.898, p<0.001).
Over half (59.3%) of the PMVs indicated that some 
clients with prolonged cough they treated got bet-
ter. Similarly, 5.2% of the PMVs indicated that all 
the suspected TB cases they treated got better. The 
large majority (76.7%) of the PMVs referred the sus-
pected TB cases, if they failed to improve.   
Referral practices among patent medicine 
vendors
Table 5 shows that 78.4% of the PMVs would likely 
refer clients with prolonged cough (>2 weeks) to 
private hospitals. Others would refer this category 
of clients to medical laboratories (20.9%). Those in 
the urban communities (81.3%) would more likely 
refer their clients to private hospitals (χ2=4.784, 
p=0.021).  
According to the leaders of PMV associations, the 
PMVs often referred clients to the nearest hospitals 
when they ever-referred. Incidentally, these nearest 
hospitals are often the private-for-profit hospitals. 
In his words: 
… If the problem becomes complicated, we 
tell the person to take him/her to the nearby 
hospital. These are mostly the private clinics 
where you may find a doctor….  
On actual referral practices, 77.6% of the PMVs had 
ever-referred their clients with prolonged cough. 
On the other hand, 66.0% had ever-referred the 
suspected TB cases. At least one-third of the PMVs 
waited for more than one month to refer clients 
with prolonged cough. The average waiting period 
was 39 days, and this was more among the urban 
PMVs (χ2=30.136; p<0.001).
One of the leaders of the PMV association argued: 
… It is the sick, the person with boil who knows 
where it hurts …. It is the asthma or TB patient 
who will tell what he has since we are not 
doctors to administer test and know if it is or-
dinary cough. So, they are the ones to ask for 
referral before we refer them….
Table 5 also shows that 89.9% of the PMVs would 
not refer their clients if the symptoms disappear. 
Other reasons for not referring clients included the 
fact that the PMVs feared that the client might not 
return to their facilities for treatment after the test-
ing (75.3%). All the rural PMVs and 91.2% of their 
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urban counterparts indicated that they would not 
refer their clients with prolonged cough or those 
suspected with TB because they can handle all cases.
The figure further reviewed the referral practices of 
the PMVs on different respiratory health problems. 
It showed that the referral practices differed with the 
nature of the respiratory problem. For instance, 
in the cases of prolonged cough, pneumonia, and 
chesty cough, large proportions of the PMVs rarely 
made any referral. In the case of cold and catarrh, a 
majority (62.5%) of the PMVs never referred their 
clients. However, in situations where they suspect-
ed TB cases, they always referred the patients.
Awareness of directly-observed treatment 
short-course clinics
More than half (58.2%) of the PMVs had never 
heard of DOTS clinics. Seven in every 10 (65.4%) 
of those who indicated awareness of DOTS clinics 
also indicated that they were aware of the existence 
of DOTS clinic in their LGA. The lack of awareness 
Table 4. Distribution of respondents (n=388) by treatment of prolonged cough (>2 weeks) and suspected 
TB cases 
Treatment Rural Urban Total
Treatment of prolonged cough
   Yes
   No
98 (85.2)
17 (14.8)
220 (79.9)
53 (20.1)
318 (82.0)
70 (18.0)
Treatment of suspected TB cases
   Yes
   No
18 (15.7)
97 (84.3)
94 (34.4)
179 (65.6)
112 (28.9)
276 (71.1)
Source of drugs
   Hospital
   Open market
   Doctors around
   Pharmacies
   Company representatives
1 (1.0)
95 (96.0)
67 (67.7)
74 (74.7)
4 (4.0)
14 (6.5)
188 (85.5)
128 (58.2)
133 (60.5)
24 (10.9)
15 (4.7)
283 (88.7)
195 (61.1)
207 (64.9)
28 (8.8)
Recognition of fake drugs
   Efficacy on clients
   Physical look of drug
   NAFDAC number
   The source
76 (76.8)
16 (16.2)
12 (12.6)
8 (8.1)
144 (66.1)
91 (41.7)
24 (11.1)
2 (0.9)
220 (69.4)
107 (33.8)
36 (11.6)
10 (3.2)
Usual outcome of treatment for those 
with prolonged cough
   They all get better
   Some get better
   Some get worse
   All get worse
   Cannot say
18 (18.4)
63 (64.3)
6 (6.1)
-
11 (11.2)
50 (22.8)
125 (57.1)
32 (14.6)
1 (0.5)
11 (5.0)
68 (21.5)
188 (59.3)
38 (12.0)
1 (0.3)
22 (6.9)
Usual outcome of treatment for 
suspected TB cases
   They all get better
   Some get better
   Some get worse
   All get worse
   Cannot say
2 (11.1)
6 (33.3)
2 (11.1)
-
8 (44.4)
4 (4.1)
28 (28.9)
9 (9.3)
3 (3.1)
53 (54.6)
6 (5.2)
34 (29.6)
11 (9.6)
3 (2.6)
61 (53.0)
Next step if condition fails to improve
after treatment of suspected TB cases
   Change treatment
   Increase dosage
   Refer clients to other facilities
   Do nothing
3 (16.7)
-
11 (61.1)
4 (22.2)
6 (6.1)
6 (6.1)
78 (79.6)
14 (14.3)
9 (7.8)
6 (5.2)
89 (76.7)
18 (15.5)
Figures in parentheses indicate percentages; NAFDAC=National Agency for Food and Drug Administra-
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was more common among the urban PMVs than 
among the rural PMVs. 
Awareness of DOTS clinics also varied among the 
leaders of PMV associations. For instance, while the 
Chairman in the Akwa Ibom state indicated aware-
ness, a Secretary from a rural community in the 
same state indicated ignorance of the existence of 
the DOTS clinic. The Chairman said: 
I have heard about DOTS clinic where people are 
given drugs to take before the health person-
nel.… In fact, the first time when I heard about 
it, I thanked the Federal Government and the 
organizers of that section immensely….
On the other hand, a Secretary of a PMV associa-
tion indicated the lack of awareness of the DOTS 
clinics by saying: 
… I have not heard about it (DOTS clinic). I am 
not aware of DOTS clinic but if it is evolved, it 
will help in the control of people with tubercu-
losis in our environment.
Such variations in awareness of the existence and 
activities of the DOTS clinics were reported in the 
three states under study. While the urban PMV 
leaders were aware, their counterparts in the rural 
communities lacked knowledge of DOTS clinics. 
Half (50%) of the PMVs indicated that a few people 
Table 5. Distribution of respondents (n=388) by referral practice 
Referral practice Rural Urban Total
Likely place to refer a client with 
prolonged cough (>2 weeks)
   Private hospital
   Medical laboratory
   Government hospital
82 (71.3)
32 (27.8)
15 (13.0)
222 (81.3)
49 (17.9)
32 (11.7)
304 (78.4)
81 (20.9)
47 (12.1)
Likely place to refer a suspected TB client 
   Nowhere
   Private hospital
   Medical laboratory
   Government hospital
72 (62.6)
14 (12.2)
0 (0.0)
30 (26.1)
246 (90.1)
24 (8.8)
3 (1.1)
4 (1.5)
318 (82.0)
38 (9.8)
3 (0.8)
34 (8.8)
Ever-referred client with prolonged 
cough (>2 weeks)
   Yes
   No
80 (69.6)
35 (30.4)
221 (81.0)
52 (19.0)
301 (77.6)
87 (22.4)
Ever-referred a suspected TB client 
   Yes
   No
74 (64.3)
41 (35.7)
182 (66.7)
91 (33.3)
256 (66.0)
132 (34.0)
Average time between first contact with 
clients with cough and referral
   <1 week
   1-<2 weeks
   2-3 weeks
   <1 month
   >1 month
9 (11.3)
38 (47.5)
9 (11.3)
7 (8.8)
17 (21.3)
26 (11.8)
41 (18.6)
64 (29.0)
14 (6.3)
76 (34.4)
35 (11.6)
79 (26.2)
73 (24.3)
21 (7.0)
93 (30.9)
Reasons why referral may not be made
   If symptom disappears
   Client may return to me for treatment 
   Client may loose confidence in me
   Client may not go to referral place
   Client may go to other PMVs instead
   Client may go to traditional healers instead
   I can handle all cases
   There are no better facilities around
   The people are very poor 
105 (91.3)
88 (76.5)
88 (76.5)
23 (20.0)
24 (20.9)
25 (21.7)
115 (100.0)
15 (13.0)
35 (30.4)
244 (89.4)
204 (74.7)
204 (74.7)
46 (16.8)
39 (14.3)
31 (11.4)
249 (91.2)
57 (20.9)
75 (27.5)
349 (89.9)
292 (75.3)
292 (75.3)
69 (17.8)
63 (16.2)
56 (14.4)
364 (93.8)
72 (18.6)
110 (28.4)
Figures in parentheses indicate percentages; PMVs=Patent medicine vendors; TB=TuberculosisOnyeneho NG and Chukwu JN Patent medicine vendors and tuberculosis control
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visited the DOTS clinics while another 2.8% of the 
PMVs indicated that people did not use the DOTS 
clinics.
The low usage of the DOTS clinics was linked to ig-
norance (72.2%) and attitudes of the health workers 
at the DOTS clinics (44.4%). Other reasons were that 
people were unaware of the existence of DOTS clin-
ics (70.8%) and perceived high cost of testing and 
treatment at these DOTS clinics (9.7%). These were 
particularly striking in the rural communities.
On the other hand, many people patronized the 
PMVs because they are readily available to treat the 
people (80.7%) and have cheap treatments and 
drugs (28.4%). They are also friendly (71.1%) and 
do not delay treatment by first insisting on labora-
tory testing (22.9%).
According to a PMV, some reasons for being on the 
ground include, in his words: 
… We are in the local communities, a very in-
terior part of the community, and we deal with 
people of the local communities; hence, such 
people come to the patent medicine shop to re-
quest, “sir, do you have something like this”….
The Public Relations Officer of one of the PMV as-
socations stated: 
Some of them (clients) do not know that 
they should go for test so that  adequate treat-
ment could be known; so, they will come to us 
thinking we can handle….
Involvement of patent medicine dealers in 
detection of TB cases 
Table 6 shows that 81.7% of the PMVs agreed that 
involving the PMVs would increase case-detection. 
Most (87.1%) agreed that the PMVs would be glad 
to demonstrate their relevance in disease control. 
Further, 78.4% agreed that the PMVs would see 
DOTS clinics as opportunities for free-testing and 
treatment of their clients. These signify positive dis-
position towards the involvement of PMVs in TB 
control.
However, on other issues that indicate negative dis-
position towards the involvement of PMVs in TB 
control, the PMVs seemed to disagree. For instance, 
89.2% of the PMVs disagreed with the idea that the 
PMVs would be reluctant to get involved in TB con-
trol because it would kill their business. Similarly, 
90.7% of the PMVs disagreed that the PMVs would 
insist on being paid for their roles in TB control.
The majority (54.1%) of the PMVs thought that one 
best way of involving the PMVs in TB control 
was to train them on detection of TB cases. About 
one-third (37.4%) indicated that efforts should be 
made to increase awareness of detection of TB cases 
among the PMVs. Some PMVs (16.2%) indicated 
that the PMVs should be supplied with drugs for 
managing TB.  
Many (25.5%) PMVs thought that the PMVs could 
be engaged in counselling suspected TB cases to 
go for testing. The majority (60.3%) of the PMVs 
thought that the PMVs could refer suspected TB 
Fig. Referral paractices by disease conditions
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cases to the DOTS clinic. Small proportions (13.9%, 
4.1%, and 5.9%) opined that the PMVs could treat 
suspected TB cases, test suspected TB cases in their 
facilities, and do anything to help control TB res-
pectively.
A very small proportion (2.8%) of the PMVs in-
dicated that they had ever-attended training on 
TB control. Most (97.2%) had never attended 
any training on TB control. This situation did not 
differ between the rural and the urban communi-
ties.
The leaders of PMV associations also identified 
training as one way of getting the PMVs involved 
in TB control in the communities. One of the lead-
ers in Akwa Ibom state said: 
… They (PMVs) should be informed, involved, 
educated, and trained…. You will know what 
you have learnt, and if anything comes up, you 
will tell the person….
The PMVs identified possible barriers to their in-
volvement in TB-control programmes. One of 
such barriers is the level of training required for the 
handling of TB on a large scale (77.3%). The most 
commonly-mentioned barrier, however, was the 
worry about government regulations (82.0%). The 
PMVs were also concerned with the attitudes of the 
health workers in the government health facilities 
(78.1%).
The PMVs identified some opportunities that could 
facilitate their involvement in TB control. These in-
cluded the existing skills they have in handling cli-
ents with different ailments, including prolonged 
cough (100%). The other opportunities mentioned 
were the existing positive disposition of the com-
munity members to the PMVs (88.7%) and the fact 
that the handling of suspected TB cases is akin to 
handling other health problems in the communi-
ties (77.3%).
The leaders of PMV associations also identi-
fied opportunities for mainstreaming the PMVs 
into an organized TB-control efforts in the com-
munities. One of such opportunities mentioned 
was the monthly meetings of members of the as-
sociations. According to one leader of a PMV as-
sociation: 
… The monthly meetings we have are of great 
help…. We discuss about various health prob-
lems people bring…. I lecture my members in 
the meeting…. 
This is typical of the views of the leaders from the 
other states. Another leader of the PMVs empha-
sized: 
… All these things we are telling in our lectures 
in the seminars which we always hold. So, we 
have orientation, this is why you can see me be-
ing able to say all these….
Table 6. Attitudes of respondents (n=388) towards involving PMVs in detection of TB cases by locality
Attitude Agree Disagree
Involving PMDs in TB control will increase detection of TB cases in 
the communities 317 (81.7) 71 (18.3)
Involving PMDs in TB control will make no difference on detection of 
TB cases 35 (9.0) 353 (91.0)
PMDs will be reluctant to get involved because it will kill their business 42 (10.8) 346 (89.2)
PMDs will be glad to demonstrate their relevance in disease control 338 (87.1) 50 12.9)
PMDs always feel that they can handle TB cases 69 (17.8) 319 (82.2)
PMDs will see DOTS clinic as helping to provide free testing 304 (78.4) 84 (21.6)
Referring clients to DOTS clinics will be seen as delay in action 52 (13.4) 336 (86.6)
PMDs will insist on being paid for referring their clients to DOTS clinics 36 (9.3) 352 0.7)
PMDs are not bothered about testing 31 (8.0) 357 (92.0)
PMDs suspect that referring their clients to DOTS clinics is a way of 
losing their clients to their rivals, government health workers who 
actually make money in DOTS clinics 
 
 
39 (10.1)
 
 
349 (89.9)
PMDs will suspect that they might get infected while attending TB 
clients; therefore, not get involved 57 (14.7) 331 (85.3)
Figures in parentheses indicate percentages; DOTs=Directly-observed treatment short-course; 
PMVs=Patent Medicine vendors; TB=TuberculosisOnyeneho NG and Chukwu JN Patent medicine vendors and tuberculosis control
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Attitudes of community leaders and leaders 
of PMV associations towards involvement of 
PMVs in tuberculosis control
An attitudinal scale was developed to gauge the at-
titudes of the community leaders and the leaders 
of PMV associations towards the involvement of 
PMVs in TB control in the communities. The re-
sults revealed that the leaders of PMV associations 
are generally positively disposed to involving the 
PMVs in TB control in the communities, irrespec-
tive of the state. The Chairman of the PMV as-
sociation in Ogun state, for instance, agreed that 
involving the PMVs will help the health system in 
the communities. He said: 
… I agree totally because it will help the rural 
people. They would not have problems so fre-
quently as now, when they go to the test clinic. 
… It will help the people greatly…. I agree.
Another leader of a PMV association emphasized: 
… Involving the PMVs in the control of TB 
will make a difference in case-detection be-
cause they will effectively care for this person 
since it is in their neighbourhood.
DISCUSSION
Respiratory diseases generally and, indeed, pro-
longed cough which is a sign of TB infection con-
stitute some common health problems taken to the 
PMVs in the study communities. The study, thus, 
reviewed the potential roles the PMVs could play 
in TB control in southern Nigeria. They are highly 
trainable individuals aged 19-45 years. Awareness 
and patronage of the DOTS clinic being poor, cli-
ents instead visit the PMVs. And the PMVs seldom 
refer their clients, including those with prolonged 
cough and suspected TB cases, to private hospitals 
and other higher facilities but not the DOTS clinics. 
Referrals are made when the efforts of the PMV fail 
to ameliorate the condition of the client or when 
symptoms get worse or when the client demands 
to be referred. The average waiting period was 39 
days.    
The implications of such delays are not farfetched. 
The clients often engage in a process of multiple 
and varied healthcare-seeking that Auer et al. calls 
‘shopping’ for diagnosis and treatment therapy (3), 
typical of poor patients, which often delays diag-
nosis and the start of treatment, which increases 
the likelihood of developing multidrug-resistant TB 
(2,13).   
The PMVs opined that they be trained while the 
authorities should handle drugs for the manage-
ment of TB. They identified their existing skills, 
their acceptance among the community members, 
and, of course, the similarity of the procedures of 
handling TB cases and other respiratory problems 
as opportunities for mainstreaming TB control in 
the activities of the PMVs.
Earlier studies on healthcare-seeking behaviour of 
patients revealed that health workers exploit pa-
tients and are often unfriendly, especially with poor 
patients (2,13-16). Some of them even sell the sup-
posedly free drug. According to some discussants in 
the FGD sessions, the much-taunted free drugs in 
health facilities could be likened to the process of 
obtaining bail for suspects in Nigerian Police cells 
where bails are officially free but practically paid for 
(17). 
This is in line with other studies. For instance, 
Uplekar and Shepard and Uplekar and Rangan 
revealed that people generally associated health 
workers in public-sector facilities with poor attitude 
(18-19). Auer et al. revealed that, in the Philippines, 
most TB patients buy the prescribed anti-TB drugs 
when they visit the DOTS clinics (3).  Nichter noted 
that buying anti-TB medication, rather than receiv-
ing it free at the health centre, not only aggravates 
the financial hardship of the poor, it often results 
in incomplete and/or irregular intake of drugs 
(20). These highlight the attitudes of health work-
ers towards patients, which needs improvement if 
the much-canvassed private-public partnership in 
healthcare is to be realized (21-22).    
Conclusions
The PMVs have potentials for playing a role in fa-
cilitating the detection of TB cases because they 
are not only trainable, they are skilled in handling 
other health problems of people in their catch-
ment communities. The PMVs are readily accept-
able among the community members. The current 
referral practices among the PMVs are poor because 
of the low level of awareness of DOTS clinics in the 
communities and the PMVs’ fear of losing their cli-
ents. Another factor is the confidence of PMVs in 
their ability to handle all cases. The PMVs believe 
in their ability to handle various health problems 
of the community members.  
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